Study of antibiotics for resistant infections
Part of Infections clinical trials.
This trial looks at how well two antibiotics, ceftazidime-avibactam and fosfomycin, work together to treat infections caused by highly resistant bacteria called CRE. It may help find the best way to use these medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been treated for at least 48 hours with the antibiotics ceftazidime-avibactam (CAZ/AVI) or ceftazidime-avibactam plus fosfomycin (FOS).
- You have a confirmed infection with CRE bacteria.
- You sign a consent form to join the study.
- You do not have a mixed infection with other bacteria, unless all the bacteria are of the Enterobacterales type and are sensitive to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how well two strong antibiotics (ceftazidime/avibactam and cefiderocol) work, with or without another drug called fosfomycin, for treating tough Gram-negative infections. It aims to help doctors understand the best way to use these medicines.
This study tests whether combining two antibiotics (ceftazidime and fosfomycin) works better than ceftazidime alone for hospitalized adults with serious bacterial infections. If you have a severe infection thought to be caused by Gram-negative bacteria, this trial may offer a new treatment option.
This study compares two ways of giving preventive antibiotics to liver transplant patients who carry resistant bacteria. The goal is to see if targeted antibiotics work better than standard ones at preventing infections without causing more side effects.
This trial tests a new antibiotic combination, cefepime/enmetazobactam, against standard therapy for people with complicated urinary tract infections that have spread to the bloodstream. It aims to see if the new drug works better and is safe.
This trial tests two different schedules of a combination of antibiotics (ceftazidime-avibactam plus aztreonam) for people with serious infections caused by bacteria that are hard to treat. It aims to find the best way to give these medicines.
This trial compares different ways of giving the antibiotic ceftazidime/avibactam to see which works best. It is for people with infections caused by a type of bacteria that is hard to treat (called multidrug-resistant) but still responds to this medicine.
Hear when a new Gram Negative Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.